Isabelle Hansenne-Cervantes resume

1. Isabelle Hansenne - Cervantes PharmD, PhD
2 Faulkner Drive Tel: Home +1 (908) 928 0923
Cell +1 (908) 821 7525
Westfield, NJ 07090 -USA e-mail : cervantesisa@gmail.com
_______________________________________________________________________
_
Profile
Results focused global executive with expertise in senior research and development of Consumer
products. Strong organizational, leadership and strategic skills with a focus on bringing new innovative
products to market in a timely and cost effective process. Extensive experience in developing alliances
internally and externally and partnering with Marketing, Technology and Supply Chain leaders to drive
development and commercialization. Top brands include, L’Oreal, Kiehl’s and The Body Shop .
Holder of 97 patents .
Professional Experience
Colgate Palmolive 2008 – May 2009
Vice President – Research & Development Oral Care
Leader of a team of 42 people , including the Vice President of Clinical Studies, the Director of
Formulation, the Director of Consumer Evaluation and the Director of Claims.
• Project Leader in the breakthrough renovation of the Mouthwashes: led design and
developed products for Mass market (Plax) by using the technology roadmap process.
Worked with regional implementation teams for ensuring globalization.
• Development of Professional products for the Dentists and Pharmacy lines for each category
(caries, whitening, plaque, gingivity, sensitivity, dry mouth, erosion…): interacted with
business leaders to provide input into overall franchise strategy development, with the
goal of driving innovation and profitable growth.
• Set strategic direction as well as operational goals for Clinical Studies. Established Metrics
activities for Early Research and for Product Development to optimize and prioritize
portfolio resources for substantiation of the claims supporting the products in launch
mode.
• Managed the Evaluation of the products launched worldwide: developed and leveraged
consumer insights. Translated insight into claims by creating new tests. Prioritized tests
based on business needs.
L’Oreal USA 1999 - 2007
Vice President – Research & Development Skin Care, Sun Care and
Hygiene (2006 – 2007)
Led a team of 35 people , including the Assistant Vice President of Product Development, the Assistant
Vice President of Clinical Studies, the Director of Apply Research and the Director of Consumer
Evaluation.
• Head of The Body Shop Laboratories. The originality and the specificity of this brand is
the use of Community Trade Ingredients . Performed tests for evaluating the efficacy
of these ingredients. Developped a worldwide certified Organic line of skincare
products

2. • Formulation of new products for Kiehl’s in all the skin care categories: facial skin care with
a complete Yerba Mate Tea line, body skin care with a limited edition of cleansers and
lotions, expansion of the Men franchise Facial Fuel, new initiatives in the Dermatologist
Solutions with an Over Night Biological Peel and a High Potency Skin Firming
Concentrate. The originality of this brand is mainly the use of natural ingredients that
have been proven to be active.
• Led the Evaluation of the products launched in the US, to guarantee that the aesthetic of the
products would satisfy consumers; worldwide,
• Successfully set up the clinical studies to support the efficacy claims.
• Organized a medicalized Spa with the reformulation of Skin Ceuticals to expand the brand
outside of the USA while introducing new technologies in the launch of new products. Since the
oxidation of the cells in the skin is one of the major origins of Skin Aging led successfully a
specific research program with internal and external experts to find out new and original actives
and concepts, starting with the selection of the ingredients through in vitro testing on cells, then
on reconstructed skin and finally on skin
• Formulation of daily use moisturizers and sunscreens with Mexoryl SX, the new UVA filter,
recently approved by the FDA (La Roche Posay Anthelios SX, L’Oreal Revitalift,
Lancôme UV Expert, Vichy Capital Soleil….). The UVA protection has been a strategic
orientation that has required a significant team work to understand the need for an
optimized protection across the entire UVA and UVB spectrum.
• Launch of a new peel routine using a unique patented technology, the LHA, for anti-aging
and hyperpigmentation, in order to expand Biomedic in Europe and to renovate the
peelings in the USA. I managed to set up a task-force including teams in several
European countries, in Brazil and in the USA for the screening of the new actives, their
safety and efficacy evaluations in vitro and in vivo. The multiple and different
regulations have been taken into account for this launch.
Assistant Vice President – R&D Skin Care, Sun Care and Hygiene ( 2003 – 2005)
Addition of the Luxury Divisions to my responsibilities with Ralph Lauren and Kiehl’s. While renovating
the existing Kiehl’s catalogue, I have added new franchises like the Dermatologist Solutions’ line, using
technologies coming from Dermatology area (microdermabrasion, home peel and healing product) and I
have created the new franchises in anti-aging with Abyssine and Chryste Marine.
Director – Research & Development Sun Care and Active Cosmetic ( 1999 – 2002)
• Development of Sun Care products with high UVA protection by using Avobenzone,
photostabilised by Octocrylene for the brands Ombrelle, Lancome, Kiehl’s, Vichy,
Biotherm.
• Worked on projects with Galderma for filling 4 Mexoryl SX New Drug Applications
(Mexoryl SX is a new UVA photostable filter).
• Handled the development of professional products for Plastic Surgery and Dermatology,
especially the peeling products: Biomedic Micropeel with Glycolic Acid and Micropeel
Plus with Salicylic Acid.
L’Oreal France 1985 -1998
Director – Research & Development Sun Care (1993 -1998)
• Development of 12 lines of sun products for Europe, Japan, Canada, Australia
• Outstanding products:
 Ambre Solaire photostable with Mexoryl SX

3.  Capital Soleil for Vichy, preservative free
 Lancome with pure Vitamine E
 La Roche Posay containing Mexoryl XL, a new UVB-UVA filter for Europe.
Manager – Applied Research Sun Care (1989 – 1993)
Worked on:
• The development of the new UVA filter Mexoryl SX and another silicone derivated Mexoryl XL
• The photostabilization of Parsol 1789
• The activity of the synthetic melanin as an antioxidant.
Manager – Applied Research Scalp Care ( 1985 – 1989)
• After filling an AMM in Europe, development of a product for Hair growth “Neoxidil”
(Galderma) containing Minoxidil.
• Launched a hair care product with the Niosome technology “Nutribase” (Kerastase) and a
hair product with the Liposome technology “Serum Regulateur” (Kerastase).
Education
PhD of Biochemistry, Paris – France 1986
Graduated of the Industrial Pharmaceutical Institute – Paris – France 1985
Doctor of Pharmacy, Tours – France 1982
Patents
97 patents (available upon request) in areas of Oral Care, Skin Care, Sun Care and Hygiene.
Professional Affiliations
International Association for Dental Research Member since 2008
American Academy of Dermatology Member since 2003
Publications
Organized the communication of the clinical studies through posters at the AAD, EADV, and Dermatology
Worldwide congress for supporting the launch of new products. (see Addendum)

4. Addendum
Publications
- Evaluation of the skin firming benefits of a topical product containing hyaluronic acid and
oligopeptides on the face, neck, upper chest and hands. EADV Congress 2007
- Evaluation of the effects of topical antioxidants composition containing vitamins C,E and Ferulic
acid on special molecular biomarkers of oxidative stress in skin of healthy subjects after UVA 1-
irradiation. EADV Congress 2007
- A dermatologic evaluation of the tolerance and efficacy of a topical antioxidant composition
containing vitamins C, E and Ferulic acid. EADV Congress 2007.
- A twelve-week, clinical evaluation of the skin firming benefits of a topical product containing
Hyaluronic acid and oligo peptides on the face, neck, upper chest and hands . 2007 Dermatology
Worldwide Congress
- Multi-Center, clinical evaluation of a broad spectrum sunscreen moisturizer containing a new
photostable UVA/UVB complex for treatment of photodamage facial skin. 2007 Dermatology
Worldwide Congress
- A twenty four-week, dermatologic evaluation of the efficacy and tolerance of a topical antioxidant
product containing vitamins C, E and Ferulic acid for photodamage skin. 2007 Dermatology
Worldwide Congress
- Photoprotection effect of different topical antioxidants on ultraviolet A induced erythema and
pigmentation. 2007 Dermatology Worldwide Congress
- Clinical evaluation of the efficacy and tolerance of Capryoyl Salicylic acid peel compared to a
glycolic acid peel in subjects with fine lines and wrinkles and hyperpigmentation. 2007
Dermatology Worldwide Congress
- A seven-week, split face, double blind trial evaluation of the effectiveness and tolerability of two
facial peels on females with mild to moderate photodamaged facial skin, 2007 Dermatology
Worldwide Congress

5. - Prevention of Genomic Damage afforded by three sunscreen products having the same SPF :
Beneficial Effect of Mexoryl SX. American Society for Photobiology 2008
- A dermatologic evaluation of the tolerance and efficacy of a topical antioxidant composition
containing vitamins C, E and Ferulic acid. AAD 2008
- Multi-center, clinical evaluation of a broad spectrum sunscreen moisturizer containing a new
photostable UVA-UVB complex for treatment of photodamage facial skin. AAD 2008
- Evaluation of the skin firming benefits of a topical product containing hyaluronic acid and oligo
peptides on the face, neck, upper chest and hands. AAD 2008
- Comparative clinical assessment of two skin lightening products in female subjects with
dyschromia. AAD 2008
- Evaluation of photostability of a suncare product under UV exposure in humans. AAD 2008
- Photoprotection effect of different topical antioxidants on ultraviolet A induced erythema and
pigmentation. AAD 2008
- Daily photoprotection afforded by two sunscreen products with same SPF : Beneficial effect of
Mexoryl SX . AAD 2008